The Innovative Health Initiative-funded PROMINENT project is advancing the use of AI to assist clinicians in diagnosing cognitive impairments with greater precision, thereby improving care for patients. By focusing on patient-centred approaches, the project aims to provide clearer, personalised information to those affected by neurodegeneration. Alzheimer Europe leads the communication, dissemination, and Public Involvement activities of the project and engaged members of the project’s Public Involvement Board to learn about their thoughts about AI tools for dementia diagnosis and individualised printouts. These have been shared as part of a campaign during World Alzheimer’s Day. Here is what they thought:
Alfred Wallace highlights the value of AI-based decision support: "AI-based tools are a valuable addition. I also believe that it helps patients and their families to receive printouts of their diagnosis and test results.”
Kevin Quaid stresses the importance of using all available resources: "I do believe that every and all resources should be made available to doctors, AI-based clinical decision support will hopefully speed up diagnosis and doctors would hopefully be able to see comparisons between patients and get a better understanding of this disease.”
Nigel Hullah discusses the integration of AI in clinical practice: " The integration of AI-based clinical decision support tools in diagnosing dementia could offer numerous benefits, enhancing the accuracy, efficiency and effectiveness of the diagnostic process. Individualised printouts from doctors can be highly beneficial for patients in understanding their diagnosis and test results."
Sonata Mačiulskytė reflects on how AI can ease the shock of a dementia diagnosis: "Whilst people may suspect they have dementia, the diagnosis is always a shock, both for them and their families. If AI can save time and enable more focused but understandable information, I’m all for it."
